Clinical trials
Phase 4 Glaucoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
184 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 4 |
| 2003 | 5 |
| 2004 | 3 |
| 2005 | 7 |
| 2006 | 10 |
| 2007 | 15 |
| 2008 | 15 |
| 2009 | 20 |
| 2010 | 11 |
| 2011 | 14 |
| 2012 | 12 |
| 2013 | 8 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 6 |
| 2021 | 6 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 125 |
| Unknown status | 25 |
| Terminated | 12 |
| Recruiting | 9 |
| Withdrawn | 7 |
| Not yet recruiting | 4 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alcon Research | 36 |
| Allergan | 12 |
| Aristotle University Of Thessaloniki | 9 |
| Glaukos Corporation | 8 |
| Innovative Medical | 5 |
| Federal University of São Paulo | 4 |
| Indiana University | 4 |
| CHA University | 3 |
| Medical University of Vienna | 3 |
| Nova Scotia Health Authority | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glaucoma | 184 |
| Ocular Hypertension | 63 |
| Glaucoma, Open-Angle | 49 |
| Eye Diseases | 8 |
| Dry Eye Syndromes | 6 |
| Cataract | 5 |
| Hypertension | 4 |
| Low Tension Glaucoma | 4 |
| Hyperemia | 2 |
| Blepharoptosis | 1 |
Trials
Showing 1 to 25 of 184. Each trial links to its page on Pharma Observatory.
84 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.